A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Centro Oncológico Johns Hopkins Kimmel Bloomberg~Instituto Kimmel de Inmunoterapia contra el Cáncer y el Facultad de Medicina de la Universidad Johns Hopkins.
